Skip to main content
. 2019 Nov 6;12(2):150–154. doi: 10.1111/luts.12295

Table 2.

Summary of adverse events (safety analysis set; N = 6)

Event, n Subject, n (%)
Adverse event 4 4 (66.7)
Breath odor 4 4 (66.7)
Drug‐related adverse event 4 4 (66.7)
Breath odor 4 4 (66.7)
Serious adverse event 0 0
Drug‐related serious adverse event 0 0
Adverse event leading to discontinuation 0 0
Drug‐related adverse event leading to discontinuation 0 0